Fisher Asset Management’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-23,864
Closed -$1.06M 993
2022
Q2
$1.06M Buy
23,864
+9,800
+70% +$435K ﹤0.01% 623
2022
Q1
$696K Buy
14,064
+4,507
+47% +$223K ﹤0.01% 672
2021
Q4
$487K Hold
9,557
﹤0.01% 765
2021
Q3
$533K Hold
9,557
﹤0.01% 722
2021
Q2
$409K Buy
9,557
+2,884
+43% +$123K ﹤0.01% 750
2021
Q1
$279K Sell
6,673
-2,332
-26% -$97.5K ﹤0.01% 803
2020
Q4
$419K Sell
9,005
-31
-0.3% -$1.44K ﹤0.01% 737
2020
Q3
$384K Sell
9,036
-5,300
-37% -$225K ﹤0.01% 700
2020
Q2
$688K Hold
14,336
﹤0.01% 619
2020
Q1
$659K Hold
14,336
﹤0.01% 588
2019
Q4
$861K Sell
14,336
-3,507
-20% -$211K ﹤0.01% 600
2019
Q3
$1.01M Hold
17,843
﹤0.01% 610
2019
Q2
$993K Sell
17,843
-91
-0.5% -$5.06K ﹤0.01% 604
2019
Q1
$905K Buy
17,934
+9
+0.1% +$454 ﹤0.01% 591
2018
Q4
$722K Hold
17,925
﹤0.01% 621
2018
Q3
$1.24M Sell
17,925
-2,827
-14% -$196K ﹤0.01% 570
2018
Q2
$1.57M Sell
20,752
-9,032
-30% -$683K ﹤0.01% 548
2018
Q1
$1.57M Hold
29,784
﹤0.01% 538
2017
Q4
$1.59M Buy
29,784
+5,863
+25% +$313K ﹤0.01% 544
2017
Q3
$1.43M Buy
23,921
+12,876
+117% +$768K ﹤0.01% 531
2017
Q2
$871K Buy
11,045
+3,365
+44% +$265K ﹤0.01% 550
2017
Q1
$637K Buy
7,680
+1,900
+33% +$158K ﹤0.01% 544
2016
Q4
$459K Sell
5,780
-3,770
-39% -$299K ﹤0.01% 571
2016
Q3
$669K Sell
9,550
-2,911
-23% -$204K ﹤0.01% 543
2016
Q2
$555K Hold
12,461
﹤0.01% 550
2016
Q1
$464K Hold
12,461
﹤0.01% 571
2015
Q4
$1.11M Hold
12,461
﹤0.01% 503
2015
Q3
$922K Buy
+12,461
New +$922K ﹤0.01% 500